The leading science and technology company Merck KGaA, Darmstadt, Germany partners with US-based Centers for Disease Control and Prevention (CDC)-recognized, Diabetes Prevention Program provider Blue Mesa Health to pilot the program in territories outside of the United States.
SAN FRANCISCO, CA—(January 10, 2018) - Blue Mesa Health Inc., a US-based digital therapeutics company with offices in New York and Vancouver, BC, is pleased to announce the launch of Transformemos, a Spanish-language Diabetes Prevention Program within the Solera Health network of preventive health programs.
Since our inception, Blue Mesa Health has been committed to helping give people the tools and support they need to live chronic-disease free in the United States, Canada, UK and globally. We are proud to be pioneering digital therapeutics and diabetes prevention in Canada and proud to partner with Canadian investment firm Nimbus Synergies Inc. to support our growth:
We at Blue Mesa Health are proud to introduce Transformemos, our digital diabetes prevention program based on the CDC’s Prevenga el T2 Spanish-language program and developed from the ground up for the Hispanic/Latino cultural context.
En Blue Mesa Health estamos orgullosos de presentar Transformemos, nuestro programa digital de prevención de la diabetes basado en el programa Prevenga el T2 en español del CDC y diseñado culturalmente para servir a miembros de la comunidad Hispana y Latina.
NEW YORK, NY / VANCOUVER, BC (Sep 27, 2016) - Blue Mesa Health Inc., a US-based company with offices in New York and Vancouver, is pleased to announce that it has secured Series AA financing from Mobio Technologies Inc. (TSX VENTURE:MBO)(MBIOF), ("Mobio")), a Canadian-based company, with offices in Vancouver and New York.
Blue Mesa Health is growing and delivering our remotely-delivered diabetes prevention program to more and more participants. Health coaches are an important part our program and we are happy to announce that we are looking for great people to join our team in a Health Coach role.
2016 is shaping up to be an exciting year for Blue Mesa Health!
We have a few announcements to make:
We’re joining Blueprint Health.
This week we are pleased to announce we are partnering with Blueprint Health to accelerate our ability to help at-risk individuals prevent the onset of chronic disease with best-in-class digital behavioral change programs.
On Thursday, February 4, in the Blueprint Health accelerator space in downtown New York, over eighty people gathered to meet the latest cohort of companies to join one of the country’s top accelerators with a focus on health technology. Those in attendance included prominent health technology founders, investors, mentors and health industry executives.
By partnering with Blueprint Health we are in the company of ventures such as GlucoIQ, Healthify, and Oculus Health, just a few of many companies who have gone on to have great success subsequent to participating in Blueprint Health’s 3-month acceleration program.
For more information about us and other ventures in the Blueprint Health portfolio, check out their website.
We’re Blue Mesa Health. Our flagship product, Transform, is a CDC-recognizeddigital translation of the Diabetes Prevention Program. Transform is already making an impact by helping individuals lose weight and reduce their chances of developing type 2 diabetes.
We’re very pleased today to take another step forward in helping thousands of Americans reduce their risk for Type 2 Diabetes. We are partnering with Solera Health to deliver Transform, our translation of the Diabetes Prevention Program. With this partnership, Blue Mesa Health will be able to reach more individuals who can benefit from Transform, and Solera Health will be able to offer their clients a digitally-delivered diabetes prevention program.